Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07174622 · ClinicalTrials.gov registry record

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by Medtronic Vascular.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT07174622 is a study of Hypertension and Cardiovascular Diseases that is actively recruiting participants, run by Medtronic Vascular. The registered enrollment target is 1,000 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07174622, a study of Hypertension and Cardiovascular Diseases, is actively recruiting participants, sponsored by Medtronic Vascular.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. Patients are enrolled through the submission of claims or encounter data to CMS.

Interventions

  • DEVICE Renal Denervation (Symplicity Spyral™)

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-10-28
Est. Completion 2029-06

Sponsor

Medtronic Vascular

26 total trials

What the Registry Record Tells You About NCT07174622

The ClinicalTrials.gov registry entry for NCT07174622 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Renal Denervation (Symplicity Spyral™) is the first listed.

NCT07174622 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07174622 about?

NCT07174622 is a clinical study titled "Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation". This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. ...

What is the current status of trial NCT07174622?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-10-28. Estimated completion is 2029-06.

What conditions does trial NCT07174622 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases.

What interventions are being tested in trial NCT07174622?

The interventions under investigation include: Renal Denervation (Symplicity Spyral™) (DEVICE).

Who is sponsoring clinical trial NCT07174622?

This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07174622 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.